Indefinite Delivery Contract HHSF223201510026I

Award Date 8/3/15
Last Date to Order 2/19/21
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc., a prominent management, technology, and engineering services firm. The BPA has a ceiling value of $150,000,000 and a period of performance through December 17, 2025. The BPA supports the FDA's CTP BPA IT Systems Lifecycle Development and Management Support program, under which Booz Allen Hamilton has been awarded several task orders. These task orders...
The Federal Contract IDV award is a single-award Indefinite Delivery Contract valued at up to $3,446,837.42 for a period of performance from May 16, 2023 to May 16, 2026. The contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Syneos Health Research & Insights LLC. The contract aims to provide the FDA with access to healthcare practitioner prescribing practices data. The original solicitation was a combined synopsis/solicitation for commercial items,...
The federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a) minority-owned small disadvantaged business. The $98.83 million BPA supports the FDA's "ADVANCING REGULATORY SCIENCE FOR CLINICAL EVIDENCE GENERATION, ASSESSMENT, AND ANALYTICS" initiative, providing a range of data analytics, AI/ML, healthcare IT, and management consulting services to modernize...
The federal contract IDV award is an Indefinite Delivery Contract (IDC) held by The Bionetics Corp, a for-profit engineering firm based in Richmond, VA. The contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, with a total ceiling value of $12,301,085. The IDC covers a variety of "OTHER PROFESSIONAL SERVICES" including calibration and inspection services for tools, meters, and equipment; animal care, husbandry and technical procedures support; test...
This Blanket Purchase Agreement (BPA) is a multiple award IDV (Indefinite Delivery Vehicle) awarded by the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc. The contract is part of the "Modernizing FDA Data and Analytics" program, with a total ceiling value of $500,000,000 and a period of performance through August 26, 2029. Booz Allen Hamilton, a prominent management and technology consulting firm, will provide a wide range of professional services to the FDA under this...
The federal contract IDV is an Indefinite Delivery Contract (IDC) awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS). The contract, with a ceiling value of $4,000,000.00, was awarded to Bracane Company, an 8(a) certified economically disadvantaged women-owned small business. The contract, titled "RECALL & AUDIT IDIQ CONTRACT," has a period of performance ending on September 16, 2029. The first task order...
The Department of Health and Human Services Food and Drug Administration awarded a Blanket Purchase Agreement to General Dynamics Information Technology, Inc. to provide a range of information technology services and products in support of FDA programs. The potential value of the IDV is $140 million with task orders awarded through 2026. Task orders awarded under the BPA include knowledge acquisition and situation awareness technical support services in Silver Spring, Maryland valued at $16.96...
The Department of Health and Human Services' Food and Drug Administration awarded a Blanket Purchase Agreement to Booz Allen Hamilton Inc. to provide various information technology services in support of FDA programs. Under the BPA, three call contracts have been issued totaling over $35 million. The first call awarded Booz Allen a $221,556 contract to analyze IT needs and develop a roadmap for FDA's laboratory operations over six months. A second call valued at $9.2 million retains Booz Allen...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded Booz Allen Hamilton Inc., a subsidiary of Booz Allen Hamilton Holding Corporation, a Blanket Purchase Agreement (BPA) valued at up to $35 million for the Real-World Application for Innovation and Development (RAPID) Version V program. This multiple award schedule (MAS) contract vehicle allows the FDA to access a range of professional services and solutions from Booz Allen Hamilton to support the agency's...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian federal agency, to Iqvia Government Solutions Inc., a for-profit organization specializing in healthcare data, analytics, and research services. The contract has a ceiling value of $4,463,492.67 and a period of performance extending to July 14, 2030. The primary objective of this contract is to provide the FDA with comprehensive hospital inpatient and emergency department drug...

This federal contract IDV was awarded by the U.S. Department of Health and Human Services Food and Drug Administration (FDA) to Booz Allen Hamilton Inc., a leading provider of management, technology, and engineering services to the U.S. government. The indefinite delivery contract, valued at up to $19,998,000, is for scientific studies and analysis in support of the FDA's Center for Drug Evaluation and Research (CDER) priority programs. It is a multiple award contract without any set-aside designations.

The task orders issued under this IDV cover a range of services, including developing an opioid systems modeling policy tool, evaluating the implementation of a Benefit-Risk Framework, supporting the development of a decision support consult service, and conducting a Prescription Drug User Fee Act (PDUFA) management study. These task orders, valued between $149,445 and $1,965,088, are focused on providing analytical, technical, and advisory support to enhance the FDA's drug evaluation and regulatory functions. The work is primarily performed at Booz Allen Hamilton's facilities in McLean, Virginia, with performance periods ranging from one to four years.

Generated 12/24/24, 9:15 AM